Sauvage Eric, Herman Raphaël, Petrella Stephanie, Duez Colette, Bouillenne Fabrice, Frère Jean-Marie, Charlier Paulette
Centre d'Ingénierie des Protéines, Université de Liège, Institut de Physique B5, B-4000 Liège, Belgium.
J Biol Chem. 2005 Sep 2;280(35):31249-56. doi: 10.1074/jbc.M503271200. Epub 2005 Jun 29.
Actinomadura sp. R39 produces an exocellular DD-peptidase/penicillin-binding protein (PBP) whose primary structure is similar to that of Escherichia coli PBP4. It is characterized by a high beta-lactam-binding activity (second order rate constant for the acylation of the active site serine by benzylpenicillin: k2/K = 300 mm(-1) s(-1)). The crystal structure of the DD-peptidase from Actinomadura R39 was solved at a resolution of 1.8 angstroms by single anomalous dispersion at the cobalt resonance wavelength. The structure is composed of three domains: a penicillin-binding domain similar to the penicillin-binding domain of E. coli PBP5 and two domains of unknown function. In most multimodular PBPs, additional domains are generally located at the C or N termini of the penicillin-binding domain. In R39, the other two domains are inserted in the penicillin-binding domain, between the SXXK and SXN motifs, in a manner similar to "Matryoshka dolls." One of these domains is composed of a five-stranded beta-sheet with two helices on one side, and the other domain is a double three-stranded beta-sheet inserted in the previous domain. Additionally, the 2.4-angstroms structure of the acyl-enzyme complex of R39 with nitrocefin reveals the absence of active site conformational change upon binding the beta-lactams.
马杜拉放线菌属菌株R39可产生一种胞外DD - 肽酶/青霉素结合蛋白(PBP),其一级结构与大肠杆菌PBP4相似。其特征在于具有高β - 内酰胺结合活性(苄青霉素对活性位点丝氨酸进行酰化反应的二级速率常数:k2/K = 300 mM⁻¹ s⁻¹)。通过在钴共振波长处的单波长反常散射,以1.8埃的分辨率解析了来自马杜拉放线菌R39的DD - 肽酶的晶体结构。该结构由三个结构域组成:一个与大肠杆菌PBP5的青霉素结合结构域相似的青霉素结合结构域,以及两个功能未知的结构域。在大多数多模块PBP中,额外的结构域通常位于青霉素结合结构域的C端或N端。在R39中,另外两个结构域以类似于“俄罗斯套娃”的方式插入到青霉素结合结构域中,位于SXXK和SXN基序之间。其中一个结构域由一侧带有两个螺旋的五链β - 折叠组成,另一个结构域是插入到前一个结构域中的双三链β - 折叠。此外,R39与头孢硝噻吩的酰基酶复合物的2.4埃结构显示,在结合β - 内酰胺后活性位点没有构象变化。